Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, December 2001, p. 3654-3656, Vol. 45, No. 12
Institute of Parasitology, University of
Zürich, CH-8057 Zürich, Switzerland
Received 20 March 2001/Returned for modification 29 June
2001/Accepted 27 August 2001
Transgenic Leishmania infantum promastigotes, which
constitutively express green fluorescent protein (GFP) in their
cytoplasm, were used to monitor the effects of antileishmanial
compounds in real time. The GFP-based assay provided a reliable measure of drug-induced inhibitory effects on protein expression, resulting in
a dynamic picture of the responses of leishmanial promastigotes to the
compounds tested.
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.12.3654-3656.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Expression of Green Fluorescent Protein as a Marker
for Effects of Antileishmanial Compounds In Vitro
*
Corresponding author. Mailing address: Institute of
Parasitology, University of Zürich, Winterthurerstrasse 266a,
8057 Zürich, Switzerland. Phone: 41-1-635-8526. Fax:
41-1-635-8907. E-mail: ahehl{at}vetparas.unizh.ch.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |